Related Experiment Videos
Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma
A A Jagasia1, J A Block, M O Diaz
1Department of Medicine, Loyola University Medical Center, Maywood, IL 60153, USA.
Abstract:
Cytogenetic abnormalities of chromosome 9 (9p21) have been reported in a large number of tumors that include malignant melanomas, gliomas, lung cancers and leukemias. These aberrations on 9p have been previously shown to involve the loss of the interferon gene cluster and the gene for methylthioadenosine phosphorylase (MTAP), both of which have been mapped to the 9p21 region. Recently, two putative tumor suppressor gene(s) CDKN2 and MTS2, have been mapped to the 9p21 region, and have been shown to be deleted in a large number of hematopoietic and solid malignancies. In this study we report a cytogenetic and a detailed molecular analysis of a myxoid chondrosarcoma cell line 105KC and its clonal derivatives 105AJ, 105AJ1.1, 105AJ3.1, and 105AJ5.1. Specifically, we have demonstrated chromosome 9p21 related abnormalities by cytogenetic analysis, the associated loss of the interferon gene cluster, and the loss of the immunoreactive MTAP protein and activity. In addition, we have also shown the presence of deletions involving the CDKN2 and the MTS2 putative tumor suppressor genes in these chondrosarcoma cell lines. The above studies were extended to other chondrosarcoma cell lines and primary tumors, where similar deletions of the CDKN2 and MTS2 genes were found to be present (unpublished data). This suggests a potential role for the involvement of the CDKN2 and MTS2 putative tumor suppressor genes in the development of chondrosarcomas.
Insights
Cytogenetic abnormalities at chromosome 9p21, including loss of tumor suppressor genes CDKN2 and MTS2, are implicated in chondrosarcoma development. This study analyzes these genetic changes in chondrosarcoma cell lines and primary tumors.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Chromosome 9p21 abnormalities are common in various cancers.
- This region harbors the interferon gene cluster, methylthioadenosine phosphorylase (MTAP), and putative tumor suppressor genes CDKN2 and MTS2.
- Previous research indicates deletions in these genes in numerous malignancies.
Purpose of the Study:
- To perform cytogenetic and molecular analysis of chondrosarcoma cell lines.
- To investigate the involvement of chromosome 9p21 abnormalities, including CDKN2 and MTS2 deletions, in chondrosarcoma.
- To assess the potential role of these tumor suppressor genes in chondrosarcoma development.
Main Methods:
- Cytogenetic analysis of chondrosarcoma cell lines (105KC and derivatives).
- Molecular analysis to detect deletions of the interferon gene cluster, MTAP, CDKN2, and MTS2.
- Analysis extended to other chondrosarcoma cell lines and primary tumors.
Main Results:
- Chromosome 9p21 abnormalities were confirmed in the studied chondrosarcoma cell lines.
- Loss of the interferon gene cluster and MTAP protein/activity was observed.
- Deletions involving the CDKN2 and MTS2 tumor suppressor genes were identified in chondrosarcoma cell lines and primary tumors.
Conclusions:
- The study demonstrates chromosome 9p21 abnormalities, including CDKN2 and MTS2 deletions, in chondrosarcomas.
- These findings suggest a significant role for CDKN2 and MTS2 in the pathogenesis of chondrosarcomas.
- Further research into CDKN2 and MTS2 as tumor suppressors in chondrosarcoma is warranted.